表紙
市場調査レポート

世界の顔用注射剤市場における主要企業

Facial Injectables | Competitor Insights | Global | 2016

発行 Decision Resources Group - Medtech Solutions 商品コード 170733
出版日 ページ情報 英文 130 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
世界の顔用注射剤市場における主要企業 Facial Injectables | Competitor Insights | Global | 2016
出版日: 2016年03月30日 ページ情報: 英文 130 Pages
概要

当レポートでは、北米・欧州・アジア太平洋地域の顔用注射剤市場おける主要企業10社の概要や最新動向、販売実績、SWOT分析などを提供しており、業界全体の市場動向・治験進行状況なども盛り込んでお届けします。

第1章 顔用注射剤市場

  • 市場の現状
    • 米国
    • 欧州
    • ラテンアメリカ
  • 市場定義
  • 市場予測データ
    • 米国
    • 欧州
    • ラテンアメリカ
  • 競合概要
  • 詳細な競争環境
    • 米国
    • 欧州
    • ラテンアメリカ
  • 市場シェア
    • 米国
    • 欧州
    • ラテンアメリカ
  • 産業全体における機会と脅威
  • 市場要素および動向

第2章 ALLERGAN

  • 企業概要
  • 世界市場での販売実績
  • SWOT分析

第3章 GALDERMA

  • 企業概要
  • 世界市場での販売実績
  • SWOT分析

第4章 MERZ PHARMA

  • 企業概要
  • 世界市場での販売実績
  • SWOT分析

第5章 Laboratoires TEOXANE

  • 企業概要
  • 世界市場での販売実績
  • SWOT分析

第6章 その他の主要企業

  • 概要
  • Metacrill
  • Sinclair Pharma
  • Fidia Farmaceutici
  • Lanzhou Institute of Biological Products
  • Medytox
  • Contura

付録:調査手法

付録:略語・頭字集

付録:関連調査

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: M360FA0037

The global facial injectable market has become increasingly consolidated, with the top three companies-Allergan, Galderma, and Merz Pharma-holding the vast majority of the market share. Nonetheless, there are still a number of smaller companies entering this lucrative market and increasing competitive pressure.

This Medtech 360 Report provides comprehensive data and analysis on the top four competitors and high-level analysis on the other leading competitors in the global facial injectable market.

Questions Answered in This Report:

The global facial injectable market has become considerably more consolidated in recent years, with Galderma and Merz Pharma undergoing a number of acquisitions and partnerships to increase their competitive positions.

  • How has Galderma's position in the market changed with its newly acquired rights to sell Restylane, Perlane, EMERVEL, and Dysport in North America? How has its acquisition of rights to Sculptra Aesthetic affected its competitive position?
  • How has Merz Pharma's 2013 acquisition of Anteis affected its competitive standing?

Because of the strong growth in the facial injectable industry, companies from other industries are showing interest in entering this market.

  • What are the opportunities and threats associated with Actavis' acquisition of Allergan? What are the opportunities and threats associated with the proposed reverse merger deal with Pfizer?
  • What are the opportunities and threats associated with Nestlé's full purchase of Galderma?
  • How will these deals affect other leading facial injectable companies?

Despite Allergan, Galderma, and Merz Pharma earning the vast majority of the market share, there is still interest in this market from smaller competitors.

  • Which companies are poised to capture expanding share in the facial injectable space?
  • What strategies are these smaller companies using to gain share?

Table of Contents

Table of Contents

Tables and Figures

Executive Summary

Version History

1 Facial Injectable Market

  • 1.1 Market Highlights
    • 1.1.1 US Market Highlights
    • 1.1.2 European Market Highlights
    • 1.1.3 Latin American Market Highlights
  • 1.2 Market Definitions
  • 1.3 Market Forecast Data
    • 1.3.1 US
    • 1.3.2 Europe
    • 1.3.3 Latin America
  • 1.4 Competitive Highlights
  • 1.5 Competitive Landscape
    • 1.5.1 US Competitive Landscape
    • 1.5.2 European Competitive Landscape
    • 1.5.3 Latin American Competitive Landscape
  • 1.6 Market Shares
    • 1.6.1 US
    • 1.6.2 Europe
    • 1.6.3 Latin America
  • 1.7 Industry-Wide Opportunities and Threats
    • 1.7.1 Opportunities
      • 1.7.1.1 Increasing Patient Awareness
      • 1.7.1.2 Growing Clinical Adoption of Aesthetic Facial Injectable Procedures
      • 1.7.1.3 Increasing Popularity of Combination Treatments
    • 1.7.2 Threats
      • 1.7.2.1 Industry Consolidation
      • 1.7.2.2 Interest from Other Industries
      • 1.7.2.3 Economic Instability
      • 1.7.2.4 Alternative Products and Procedures
      • 1.7.2.5 Real and Perceived Product Limitations and Complications
  • 1.8 Market Factors and Developments

2 Allergan

  • 2.1 Company Overview
  • 2.2 Global Revenue Performance
  • 2.3 S.W.O.T. Analysis
    • 2.3.1 Strengths
    • 2.3.2 Weaknesses
    • 2.3.3 Opportunities
    • 2.3.4 Threats

3 Galderma

  • 3.1 Company Overview
  • 3.2 Global Revenue Performance
  • 3.3 S.W.O.T. Analysis
    • 3.3.1 Strengths
    • 3.3.2 Weaknesses
    • 3.3.3 Opportunities
    • 3.3.4 Threats

4 Merz Pharma

  • 4.1 Company Overview
  • 4.2 Global Revenue Performance
  • 4.3 S.W.O.T. Analysis
    • 4.3.1 Strengths
    • 4.3.2 Weaknesses
    • 4.3.3 Opportunities
    • 4.3.4 Threats

5 Laboratoires TEOXANE

  • 5.1 Company Overview
  • 5.2 Global Revenue Performance
  • 5.3 S.W.O.T. Analysis
    • 5.3.1 Strengths
    • 5.3.2 Weaknesses
    • 5.3.3 Opportunities
    • 5.3.4 Threats

6 Other Leading Competitors

  • 6.1 Overview
  • 6.2 Metacrill
  • 6.3 Sinclair Pharma
  • 6.4 Fidia Farmaceutici
  • 6.5 Lanzhou Institute of Biological Products
  • 6.6 Medytox
  • 6.7 Contura

Appendix: Methodology

Appendix: Acronyms and Initialisms

Appendix: Bibliography

Tables and Figures

  • Figure 1: Facial Injectable Market, by Product Type, Global (USD), 2014-2024
  • Figure 2: Facial Injectable Market, by Region, Global (USD), 2014-2024
  • Table 1: Facial Injectable Market Landscape, Global (USD), 2015 and 2024
  • Figure 3: Facial Injectable Revenue Market Shares, Global, 2015
  • Table 2: Facial Injectable Revenue Market Share Rankings, by Region, Global, 2015
  • Table 3: Factors Impacting the Facial Injectable Market, by Region, Global
  • Table 4: Recent Events in the Facial Injectable Market, Global
  • Table 5: Emerging Products for the Facial Injectable Market, Global
  • Table 6: Key Report Updates
  • Table 7: Geographies Covered, Global
  • Table 8: Average Currency Exchange Rates
  • Table 9: Facial Injectable Products Covered, Global
  • Table 10: Common Facial Injectable Brands
  • Table 11: Version History
  • Figure 4: Facial Injectable Market, by Product Type, Global (USD), 2014-2024
  • Figure 5: Facial Injectable Market, by Region, Global (USD), 2014-2024
  • Figure 6: Facial Injectable Market, by Product Type, US (USD), 2014-2024
  • Figure 7: Facial Injectable Market, by Country, Europe (USD), 2014-2024
  • Figure 8: Facial Injectable Market, by Product Type, Europe (USD), 2014-2024
  • Figure 9: Facial Injectable Market, by Country, Latin America (USD), 2014-2024
  • Figure 10: Facial Injectable Market, by Product Type, Latin America (USD), 2014-2024
  • Table 12: Common Facial Injectable Brands
  • Table 13: Facial Injectable Market, by Product Type, Global (USD), 2014-2024
  • Table 14: Dermal Filler Market, by Material, Global (USD), 2014-2024
  • Table 15: Facial Injectable Market, by Region, Global (USD), 2014-2024
  • Table 16: Facial Injectable Market, by Region and Country, Global (USD), 2014-2024
  • Table 17: Facial Injectable Market, by Product Type, US (USD), 2014-2024
  • Table 18: Dermal Filler Market, by Material, US (USD), 2014-2024
  • Table 19: Facial Injectable Market, by Product Type, Europe (USD), 2014-2024
  • Table 20: Dermal Filler Market, by Material, Europe (USD), 2014-2024
  • Table 21: Facial Injectable Market, by Country, Europe (USD), 2014-2024
  • Table 22: Facial Injectable Market, by Product Type, Latin America (USD), 2014-2024
  • Table 23: Dermal Filler Market, by Material, Latin America (USD), 2014-2024
  • Table 24: Facial Injectable Market, by Country, Latin America (USD), 2014-2024
  • Figure 11: Facial Injectable Revenue Market Shares, Global, 2015
  • Table 25: Facial Injectable Revenue Market Shares, by Product Type, Global, 2015
  • Table 26: Facial Injectable Revenue Market Shares, by Region, Global, 2015
  • Figure 12: Facial Injectable Revenue Market Shares, US, 2015
  • Table 27: Facial Injectable Revenue Market Shares, by Product Type, US, 2015
  • Figure 13: Facial Injectable Revenue Market Shares, Europe, 2015
  • Table 28: Facial Injectable Revenue Market Shares, by Product Type, Europe, 2015
  • Table 29: Facial Injectable Revenue Market Shares, by Country, Europe, 2015
  • Figure 14: Facial Injectable Revenue Market Shares, Latin America, 2015
  • Table 30: Facial Injectable Revenue Market Shares, by Product Type, Latin America, 2015
  • Table 31: Facial Injectable Revenue Market Shares, by Country, Latin America, 2015
  • Table 32: Factors Impacting the Facial Injectable Market, by Region, Global
  • Table 33: Recent Events in the Facial Injectable Market, Global
  • Table 34: Emerging Products for the Facial Injectable Market, Global
  • Figure 15: Allergan's Facial Injectable Revenues, by Region, as a % of Total, Global, 2015
  • Table 35: Allergan's Facial Injectable Market Share and Revenues, by Region and Product Type, Global (USD), 2015
  • Figure 16: Allergan's Facial Injectable Revenues, by Region and Product Type, Global (USD), 2015
  • Table 36: Allergan's Facial Injectable Market Share and Revenues, by Country and Product Type, Europe (USD), 2015
  • Figure 17: Allergan's Facial Injectable Revenues, by Country and Product Type, Europe (USD), 2015
  • Table 37: Allergan's Facial Injectable Market Share and Revenues, by Country and Product Type, Latin America (USD), 2015
  • Table 38: S.W.O.T. Analysis, Allergan, 2015
  • Figure 18: Galderma's Facial Injectable Revenues, by Region, as a % of Total, Global, 2015
  • Table 39: Galderma's Facial Injectable Market Share and Revenues, by Region and Product Type, Global (USD), 2015
  • Figure 19: Galderma's Facial Injectable Revenues, by Region and Product Type, Global (USD), 2015
  • Table 40: Galderma's Facial Injectable Market Share and Revenues, by Country and Product Type, Europe (USD), 2015
  • Figure 20: Galderma's Facial Injectable Revenues, by Country and Product Type, Europe (USD), 2015
  • Table 41: Galderma's Facial Injectable Market Share and Revenues, by Country and Product Type, Latin America (USD), 2015
  • Table 42: S.W.O.T. Analysis, Galderma, 2015
  • Figure 21: Merz Pharma's Facial Injectable Revenues, by Region, as a % of Total, Global, 2015
  • Table 43: Merz Pharma's Facial Injectable Market Share and Revenues, by Region and Product Type, Global (USD), 2015
  • Figure 22: Merz Pharma's Facial Injectable Revenues, by Region and Product Type, Global (USD), 2015
  • Table 44: Merz Pharma's Facial Injectable Market Share and Revenues, by Country and Product Type, Europe (USD), 2015
  • Figure 23: Merz Pharma's Facial Injectable Revenues, by Country and Product Type, Europe (USD), 2015
  • Table 45: Merz Pharma's Facial Injectable Market Share and Revenues, by Country and Product Type, Latin America (USD), 2015
  • Table 46: S.W.O.T. Analysis, Merz Pharma, 2015
  • Figure 24: Laboratoires TEOXANE's Facial Injectable Revenues, by Region, as a % of Total, Global, 2015
  • Table 47: Laboratoires TEOXANE's Facial Injectable Market Share and Revenues, by Region and Product Type, Global (USD), 2015
  • Figure 25: Laboratoires TEOXANE's Facial Injectable Revenues, by Region and Product Type, Global (USD), 2015
  • Table 48: Laboratoires TEOXANE's Facial Injectable Market Share and Revenues, by Country and Product Type, Europe (USD), 2015
  • Figure 26: Laboratoires TEOXANE's Facial Injectable Revenues, by Country and Product Type, Europe (USD), 2015
  • Table 49: Laboratoires TEOXANE's Facial Injectable Market Share and Revenues, by Country and Product Type, Latin America (USD), 2015
  • Table 50: S.W.O.T. Analysis, Laboratoires TEOXANE, 2015
  • Table 51: Acronyms and Initialisms
Back to Top